Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
TFX 
Teleflex Incorporated (TFX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: TFX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $132.29
1 Year Target Price $132.29
| 0 | Strong Buy |
| 2 | Buy |
| 11 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -7.97% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.47B USD | Price to earnings Ratio 28.88 | 1Y Target Price 132.29 |
Price to earnings Ratio 28.88 | 1Y Target Price 132.29 | ||
Volume (30-day avg) 14 | Beta 1.05 | 52 Weeks Range 108.60 - 237.50 | Updated Date 10/17/2025 |
52 Weeks Range 108.60 - 237.50 | Updated Date 10/17/2025 | ||
Dividends yield (FY) 1.12% | Basic EPS (TTM) 4.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-23 | When - | Estimate 3.4 | Actual - |
Profitability
Profit Margin 6.31% | Operating Margin (TTM) 24.16% |
Management Effectiveness
Return on Assets (TTM) 5.41% | Return on Equity (TTM) 4.36% |
Valuation
Trailing PE 28.88 | Forward PE 7.74 | Enterprise Value 7287652533 | Price to Sales(TTM) 1.8 |
Enterprise Value 7287652533 | Price to Sales(TTM) 1.8 | ||
Enterprise Value to Revenue 2.4 | Enterprise Value to EBITDA 12.12 | Shares Outstanding 44192817 | Shares Floating 44031513 |
Shares Outstanding 44192817 | Shares Floating 44031513 | ||
Percent Insiders 0.33 | Percent Institutions 103.23 |
Upturn AI SWOT
Teleflex Incorporated
Company Overview
History and Background
Teleflex Incorporated was founded in 1943 as a supplier of mechanical remote control systems. Over time, it has evolved into a global provider of medical technology products and services through organic growth and strategic acquisitions.
Core Business Areas
- Vascular Solutions: Focuses on products for diagnostic and interventional procedures, including catheters, guidewires, and sheaths.
- Interventional Urology: Offers solutions for urological conditions, including minimally invasive treatments for benign prostatic hyperplasia (BPH).
- Surgical Solutions: Provides surgical instruments, access systems, and closure devices used in various surgical specialties.
- Anesthesia: Offers a range of airway management products, including laryngeal masks and endotracheal tubes.
- OEM: Provides custom engineered OEM solutions for medical device manufacturers.
Leadership and Structure
Liam Kelly serves as Chairman, President, and Chief Executive Officer. The company has a structured leadership team with executives overseeing each business segment and functional area.
Top Products and Market Share
Key Offerings
- Arrow EZ-IO Vascular Access System: A power-driven intraosseous access system used for rapid vascular access in emergency situations. Market share varies regionally, competes with Cook Medical and Vascular Solutions(BD).
- UroLift System: A minimally invasive treatment for benign prostatic hyperplasia (BPH). Holds a significant market share in the BPH treatment space. Competitors include Boston Scientific (Greenlight Laser PVP), Olympus (TURP), and Medtronic (InterStim).
- Rusch Endotracheal Tubes: Used for airway management during anesthesia and respiratory support. Competitors include Medtronic, Smiths Medical and Drager.
Market Dynamics
Industry Overview
The medical technology industry is characterized by innovation, regulatory scrutiny, and increasing demand driven by an aging population and advances in healthcare. The industry is highly competitive and consolidating.
Positioning
Teleflex Incorporated is a mid-sized player in the medical device industry. It has a strong presence in specific niches, such as vascular access and interventional urology, where it holds leading market positions. Focus on organic growth supplemented with M&A activity to grow market share and enter new markets.
Total Addressable Market (TAM)
The medical device TAM is estimated to be several hundred billion dollars globally. Teleflex is positioned to capture growth from their niches within this total addressable market.
Upturn SWOT Analysis
Strengths
- Strong market positions in niche areas
- Diversified product portfolio
- Established distribution network
- Focus on innovation
- Experienced management team
Weaknesses
- Exposure to regulatory risks
- Reliance on acquisitions for growth
- Highly competitive market
- Vulnerable to price pressures
- Size limits scope and geographic presence compared to larger competitors.
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Partnerships with healthcare providers
- Capitalize on unmet clinical needs and innovation
Threats
- Increased competition
- Changes in healthcare regulations
- Economic downturns
- Product liability claims
- Technological obsolescence
Competitors and Market Share
Key Competitors
- MDT
- BSX
- BDX
- ABT
Competitive Landscape
Teleflex competes with larger medical device companies across various product categories. Its competitive advantages include its focus on niche markets and its ability to innovate and develop new products.
Major Acquisitions
Standard Bariatrics
- Year: 2022
- Acquisition Price (USD millions): 300
- Strategic Rationale: Expanded the company's surgical solutions portfolio into the bariatric surgery space.
Growth Trajectory and Initiatives
Historical Growth: Teleflex has demonstrated consistent revenue growth through organic initiatives and strategic acquisitions.
Future Projections: Analysts project continued revenue growth for Teleflex, driven by new product launches, market expansion, and acquisitions. Specific projections vary across analysts.
Recent Initiatives: Recent initiatives include the acquisition of medical device companies to expand its product portfolio and strategic investments in research and development.
Summary
Teleflex Incorporated is a medical device company with a diversified product portfolio and a focus on niche markets. Its historical growth has been fueled by both organic initiatives and strategic acquisitions. The company faces challenges from larger competitors, regulatory risks, and price pressures. The company has a strong position in their market and will continue to grow.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Teleflex Incorporated Investor Relations
- Company SEC Filings
- Third-party financial data providers (e.g., Yahoo Finance, Bloomberg)
- Analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change and may not be accurate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teleflex Incorporated
Exchange NYSE | Headquaters Wayne, PA, United States | ||
IPO Launch date 1988-02-18 | Chairman, President & CEO Mr. Liam J. Kelly | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 14100 | Website https://www.teleflex.com |
Full time employees 14100 | Website https://www.teleflex.com | ||
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.